Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review

Journal of Ethnopharmacology

Volumn 190, Issue , 2016, Pages 372-386

  Gholamnezhad, Zahra ^a,b   Havakhah, Shahrzad ^c   Boskabady, Mohammad Hossein ^a,b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NORTH KHORASAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antidiabetic; Antitumor; Cardioprotective; Clinical effects; Gastroprotective; Hepatoprotective; Neuroprotective; Nigella sativa; Pulmonary protective; Thymoquinone

Indexed keywords

BETAMETHASONE; CISPLATIN; GLUCOSE; HERBACEOUS AGENT; LIPID; NIGELLA SATIVA EXTRACT; NIGELLA SATIVA OIL; PROBIOTIC AGENT; THYMOQUINONE; UNCLASSIFIED DRUG; VEGETABLE OIL; BENZOQUINONE DERIVATIVE; PLANT EXTRACT;

ANTIBACTERIAL ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; BLACK CUMIN; CARDIOVASCULAR DISEASE; ENDOTHELIAL DYSFUNCTION; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; IMMUNOMODULATION; INFERTILITY; LIVER PROTECTION; METABOLIC DISORDER; NEUROLOGIC DISEASE; NONHUMAN; RESPIRATORY TRACT DISEASE; REVIEW; ANIMAL; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; ETHNOPHARMACOLOGY; ISOLATION AND PURIFICATION; MEDICINAL PLANT; PHYTOTHERAPY; PLANT SEED; PRECLINICAL STUDY; PROCEDURES; RISK ASSESSMENT; TOXICITY TESTING;

ANIMALS; BENZOQUINONES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ETHNOPHARMACOLOGY; HUMANS; NIGELLA SATIVA; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RISK ASSESSMENT; SEEDS; TOXICITY TESTS;

EID: 84978896044     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2016.06.061     Document Type: Review

References (121)

1. Abdel-Fattah, A.M., Matsumoto, K., Watanabe, H., Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone in mice. Eur. J. Pharmacol. 400 (2000), 89–97.
2. Aboul-Ela, M.A., El-Shaer, N.S., Ghanem, N.B., Antimicrobial evaluation and chromatographic analysis of some essential and fixed oils. Pharmazie 51 (1996), 993–994.
3. Adel, A.-M., Morsy, B.M., Mahmoud, A.M., AboSeif, M.A., Zanaty, M.I., Beneficial therapeutic effects of Nigella sativa and/or Zingiber officinale in HCV patients in Egypt. EXCLI J. 12 (2013), 943–955.
4. Agarwal, R., Kharya, M.D., Shrivastava, R., Antimicrobial and anthelmintic activities of the essential oil of Nigella sativa Linn. Indian J. Exp. Biol. 17 (1979), 1264–1265.
5. Ahmad, A., Husain, A., Mujeeb, M., Khan, S.A., Najmi, A.K., Siddique, N.A., Damanhouri, Z.A., Anwar, F., A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pac. J. Trop. Biomed. 3 (2013), 337–352.
6. Ahmad Alobaidi, A.H., Effect of Nigella sativa and Allium sativum coadminstered with simvastatin in dyslipidemia patients: a prospective, randomized, double-blind trial. Antiinflamm. Antiallergy Agents Med. Chem. 13 (2014), 68–74.
7. Ahmad, J., Khan, R.A., Malik, M.A., A study of Nigella sativa oil in the management of wheeze associated lower respiratory tract illness in children. Afr. J. Pharm. Pharmacol. 4 (2010), 436–439.
8. Akhondian, J., Kianifar, H., Raoofziaee, M., Moayedpour, A., Toosi, M.B., Khajedaluee, M., The effect of thymoquinone on intractable pediatric seizures (pilot study). Epilepsy Res. 93 (2011), 39–43.
9. Akhtar, M., Maikiyo, A.M., Khanam, R., Mujeeb, M., Aqil, M., Najmi, A.K., Ameliorating effects of two extracts of Nigella sativa in middle cerebral artery occluded rat. J. Pharm. Bioallied Sci. 4 (2012), 70–75.
10. Akhtar, M.S., Riffat, S., Field trial of Saussurea lappa roots against nematodes and Nigella sativa seeds against cestodes in children. J. Pak. Med. Assoc. 41 (1991), 185–187.
11. Al-Ali, A., Alkhawajah, A.A., Randhawa, M.A., Shaikh, N.A., Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J. Ayub Med. Coll. Abbottabad 20 (2008), 25–27.
12. Al-Hader, A.A., Aqel, M.B., Hasan, Z.A., Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Int. J. Pharmacogn. 31 (1993), 96–100.
13. Al-Jassir, M.S., Chemical composition and microflora of black cumin (Nigella sativa L.) seeds growing in Saudi Arabia. Food Chem. 45 (1992), 239–242.
14. Al-Jenoobi, F.I., Al-Thukair, A.A., Abbas, F.A., Ansari, M.J., Alkharfy, K.M., Al-Mohizea, A.M., Al-Suwayeh, S.A., Jamil, S., Effect of black seed on dextromethorphan O- and N-demethylation in human liver microsomes and healthy human subjects. Drug Metab. Lett. 4 (2010), 51–55.
15. Al-Rasheed, N., Bassiouni, Y., Faddah, L., Mohamad, A.M., Potential protective effects of Nigella sativa and Allium sativum against fructose-induced metabolic syndrome in rats. J. Oleo Sci. 63 (2014), 839–848.
16. Al-Sheddi, E.S., Farshori, N.N., Al-Oqail, M.M., Musarrat, J., Al-Khedhairy, A.A., Siddiqui, M.A., Cytotoxicity of Nigella sativa seed oil and extract against human lung cancer cell line. Asian Pac. J. Cancer Prev. 15 (2014), 983–987.
17. Ali, B.H., Blunden, G., Pharmacological and toxicological properties of Nigella sativa. Phytother. Res. 17 (2003), 299–305.
18. Alimohammadi, S., Hobbenaghi, R., Javanbakht, J., Kheradmand, D., Mortezaee, R., Tavakoli, M., Khadivar, F., Akbari, H., Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation. Diagn. Pathol., 8, 2013, 137.
19. Aqel, M., Shaheen, R., Effects of the volatile oil of Nigella sativa seeds on the uterine smooth muscle of rat and guinea pig. J. Ethnopharm. 52 (1996), 23–26.
20. Ave-Sina, Law in Medicine. 1990, Ministry of Guidance Publication, Teheran, 314.
21. Azzubaidi, M.S., Talib, N.A., Saxena, A.K., Ahmed, Q.U., 2011. Mnemonic effects of Fixed Oil of Black Cumin (Nigella sativa) seeds on aged rats with memory impairment. In: Proceedings of Malaysia-Australia Research Colloquium on Exercise, Nutrition, Health and Wellness, 19th−21st september, Penang.
22. Bamosa, A.O., Kaatabi, H., Lebdaa, F.M., Elq, A.M., Al-Sultanb, A., Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian J. Physiol. Pharmacol. 54 (2010), 344–354.
23. Barakat, E.M.F., El Wakeel, L.M., Hagag, R.S., Effects of Nigella sativa on outcome of hepatitis C in Egypt. World J. Gastroenterol. 19 (2013), 2529–2536.
24. Benhaddou-Andaloussi, A., Martineau, L., Vuong, T., Meddah, B., Madiraju, P., Settaf, A., Haddad, P.S., The in vivo antidiabetic activity of Nigella sativa is mediated through activation of the AMPK pathway and increased muscle Glut4 content. Evid.-Based Complement. Altern. Med., 2011, 2011, 9.
25. Benhaddou-Andaloussi, A., Martineau, L.C., Vallerand, D., Haddad, Y., Afshar, A., Settaf, A., Haddad, P.S., Multiple molecular targets underlie the antidiabetic effect of Nigella sativa seed extract in skeletal muscle, adipocyte and liver cells. Diabetes Obes. Metab. 12 (2010), 148–157.
26. Bhatti, I.U., Ur Rehman, F., Khan, M.A., Marwat, S.K., Effect of prophetic medicine kalonji [Nigella sativa l.] on lipid profile of human beings. An invivo approach. World Appl. Sci. J. 6 (2009), 1053–1057.
27. Bin Sayeed, M.S., Shams, T., Fahim Hossain, S., Rahman, M.R., Mostofa, A., Fahim Kadir, M., Mahmood, S., Asaduzzaman, M., Nigella sativa L. seeds modulate mood, anxiety and cognition in healthy adolescent males. J. Ethnopharmacol. 152 (2014), 156–162.
28. Boskabady, M.H., Farhadi, J., The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: a randomized, double-blind, placebo-controlled trial. J. Altern. Complement. Med. 14 (2008), 1137–1144.
29. Boskabady, M.H., Javan, H., Sajady, M., Rakhshandeh, H., The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients. Fundam. Clin. Pharmacol. 21 (2007), 559–566.
30. Boskabady, M.H., Kiani, S., Jandaghi, P., Comparison of antitussive effect of Nigella sativa with codein in guinea pig. Iran. J. Med. Sci. 28 (2003), 111–115.
31. Boskabady, M.H., Mohsenpoor, N., Takaloo, L., Antiasthmatic effect of Nigella sativa in airways of asthmatic patients. Phytomedicine 17 (2010), 707–713.
32. Boulos, L., Medicinal Plants of North Africa. 1983, Reference Publications, Algonac pp. 103.
33. Chaieb, K., Kouidhi, B., Jrah, H., Mahdouani, K., Bakhrouf, A., Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complement. Altern. Med., 11, 2011, 29.
34. Chakravarty, N., Inhibition of histamine release from mast cells by nigellone. Ann. Allergy 70 (1993), 237–242.
35. Chevallier, A., The Encyclopedia of Medicinal Plants. 1996, DK Publishing, New York pp. 237.
36. Daba, M.H., Abdel-Rahman, M.S., Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol. Lett. 16 (1998), 23–29.
37. Dehkordi, F.R., Kamkhah, A.F., Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam. Clin. Pharmacol. 22 (2008), 447–452.
38. Dirjomuljono, M., Kristyono, I., Tjandrawinata, R.R., Nofiarny, D., Symptomatic treatment of acute tonsillo-pharyngitis patients with a combination of Nigella sativa and Phyllanthus niruri extract. Int. J. Clin. Pharmacol. Ther. 46 (2008), 295–306.
39. Dollah, M.A., Parhizkar, S., Izwan, M., Effect of Nigella sativa on the kidney function in rats. Avicenna J. Phytomed. 3 (2013), 152–158.
40. Dollah, M.A., Parhizkar, S., Latiff, L.A., Bin Hassan, M.H., Toxicity effect of Nigella sativa on the liver function of rats. Adv. Pharm. Bull. 3 (2013), 97–102.
41. Durmuşkahya, C., Öztürk, M., Ethnobotanical survey of medicinal plants used for the treatment of diabetes in Manisa, Turkey. Sains Malays. 42 (2013), 1431–1438.
42. El-Dakhakhny, M., Madi, N.J., Lembert, N., Ammon, H.P., Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats. J. Ethnopharmacol. 81 (2002), 161–164.
43. El-Tahir, K.E., Ashour, M.M., Al-Harbi, M.M., The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. Gen. Pharmacol. 24 (1993), 1123–1131.
44. El-Tahir, K.E.H., Ashour, M.M., Al-Harbi, M.M., The respiratory effect of the volatile oil of the black seed (Nigella sativa) in guinea-pig: elucidation of the mechanism(s) of action. Gen. Pharmacol. 24 (1999), 1115–1122.
45. El-Tahir, K.E., Bakeet, D.M., The black seed Nigella sativa Linnaeus - a mine for multi cures: a Plea for urgent clinical evaluation of its volatile oil. J. Taibah Univ. Med. Sci. 1 (2006), 1–19.
46. El Kadi, A., Kandil, O., Tabuni, A.M., Nigella sativa and cell mediated immunity. Arch. AIDS Res. 1 (1990), 232–234.
47. Enomoto, S., Asano, R., Iwahori, Y., Narui, T., Okadam, Y., Singab, A.N., Okuyama, T., Hematological studies on black cumin oil from the seeds of Nigella sativa L. Biol. Pharm. Bull. 24 (2001), 307–310.
48. Fallah Huseini, H., Amini, M., Mohtashami, R., Ghamarchehre, M.E., Sadeqhi, Z., Kianbakht, S., Fallah Huseini, A., Blood pressure lowering effect of Nigella sativa L. seed oil in healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. Phytother. Res. 27 (2013), 1849–1853.
49. Farzaneh, E., Nia, F.R., Mehrtash, M., Mirmoeini, F.S., Jalilvand, M., The effects of 8-week Nigella sativa supplementation and aerobic training on lipid profile and VO2 max in sedentary overweight females. Int. J. Prev. Med. 5 (2014), 210–216.
50. Gali-Muhtasib, H., Diab-Assaf, M., Boltze, C., Al-Hmaira, J., Hartig, R., Roessner, A., Schneider-Stock, R., Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int. J. Oncol. 25 (2004), 857–866.
51. Gali-Muhtasib, H., El-Najjar, N., Schneider-Stock, R., The medicinal potential of black seed (Nigella sativa) and its components. Mahmud, T.H.K., Arjumand, A., (eds.) Advances in Phytomedicine, 2006, Elsevier, 133–153.
52. Gheita, T.A., Kenawy, S.A., Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study. Phytother. Res. 26 (2012), 1246–1248.
53. Ghorbanibirgani, A., Khalili, A., Rokhafrooz, D., Comparing Nigella sativa oil and fish oil in treatment of vitiligo. Iran. Red Crescent Med. J., 16, 2014, e4515.
54. Greenish, H.G., Contribution to the chemistry of Nigella sativa. Pharmac. J. Trans. 10 (1880), 909–911.
55. Hadjzadeh, M.A., Rad, A.K., Rajaei, Z., Tehranipour, M., Monavar, N., The preventive effect of N-butanol fraction of Nigella sativa on ethylene glycol-induced kidney calculi in rats. Pharmacogn. Mag. 7 (2011), 338–343.
56. Hagag, A.A., Elaal, A.M.A., Elsheik, A., Elzamarany, E.A., Protective effect of Nigella sativa oil against methotrexate induced hepatotoxicity in children with acute lymphoblastic leukemia. J. Leuk., 1, 2013, 123.
57. Hanafy, M.S., Hatem, M.E., Studies on the antimicrobial activity of Nigella sativa seed (black cumin). J. Ethnopharmacol. 34 (1991), 275–278.
58. Hannan, A., Saleem, S., Chaudhary, S., Barkaat, M., Arshad, M.U., Anti bacterial activity of Nigella sativa against clinical isolates of methicillin resistant Staphylococcus aureus. J. Ayub Med. Coll. Abbottabad 20 (2008), 72–74.
59. Haq, A., Lobo, P.I., Al-Tufail, M., Rama, N.R., Al-Sedairy, S.T., Immunomodulatory effect of Nigella sativa proteins fractionated by ion exchange chromatography. Int. J. Immunopharmacol. 21 (1999), 283–295.
60. Haque, S.F., Nasiruddin, M., Najmi, A., Indigenous herbal product Nigella sativa proved effective as an anti-obesity therapy in metabolic syndrome. Int. J. Med. Res. 1 (2011), 133–176.
61. Heshmati, J., Namazi, N., Effects of black seed (Nigella sativa) on metabolic parameters in diabetes mellitus: a systematic review. Complement. Ther. Med. 23 (2015), 275–282.
62. Heshmati, J., Namazi, N., Memarzadeh, M.-R., Taghizadeh, M., Kolahdooz, F., Nigella sativa oil affects glucose metabolism and lipid concentrations in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Food Res. Int. 70 (2015), 87–93.
63. Hosseini, M.S., Mirkarimi, S.A., Amini, M., Mohtashami, R., Kianbakht, S., Fallah Huseini, H., Effects of Nigella sativa L. seed oil in type II diabetic patients: a randomized, double-Blind, placebo - controlled clinical trial. J. Med. Plants 12 (2013), 93–99.
64. Houghton, P.J., Zarka, R., de las Heras, B., Hoult, J.R., Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. 61 (1995), 33–36.
65. Ibrahim, R.M., Hamdan, N.S., Ismail, M., Saini, S.M., Abd Rashid, S.N., Abd Latiff, L., Mahmud, R., Protective effects of Nigella sativa on metabolic syndrome in menopausal women. Adv. Pharm. Bull. 4 (2014), 29–33.
66. Ibrahim, R.M., Hamdan, N.S., Mahmud, R., Imam, M.U., Saini, S.M., Rashid, S.N., Abd Ghafar, S.A., Latiff, L.A., Ismail, M., A randomised controlled trial on hypolipidemic effects of Nigella sativa seeds powder in menopausal women. J. Transl. Med., 12, 2014, 82.
67. Isik, H., Cevikbas, A., Gurer, U.S., Kiran, B., Uresin, Y., Rayaman, P., Rayaman, E., Gurbuz, B., Buyukozturk, S., Potential adjuvant effects of Nigella sativa seeds to improve specific immunotherapy in allergic rhinitis patients. Med. Princ. Pract. 19 (2010), 206–211.
68. Kaatabi, H., Bamosa, A.O., Badar, A., Al-Elq, A., Abou-Hozaifa, B., Lebda, F., Al-Khadra, A., Al-Almaie, S., Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial. PLoS One, 10, 2015, e0113486.
69. Kalus, U., Pruss, A., Bystron, J., Jurecka, M., Smekalova, A., Lichius, J.J., Kiesewetter, H., Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother. Res. 17 (2003), 1209–1214.
70. Kardani, A.K., Fitri, L.E., Barlianto, W., Olivianto, E., Kusuma, H.M.S.C., The effect of house dust mite immunotherapy, probiotic and Nigella sativa in the number of Th17 cell and asthma control test score. IOSR-JDMS 6 (2013), 37–47.
71. Khader, M., Bresgen, N., Eckl, P.M., In vitro toxicological properties of thymoquinone. Food Chem. Toxicol. 47 (2009), 129–133.
72. Kolahdooz, M., Nasri, S., Modarres, S.Z., Kianbakht, S., Huseini, H.F., Effects of Nigella sativa L. seed oil on abnormal semen quality in infertile men: a randomized, double-blind, placebo-controlled clinical trial. Phytomedicine 21 (2014), 901–905.
73. Landa, P., Marsik, P., Havlik, J., Kloucek, P., Vanek, T., Kokoska, L., Evaluation of antimicrobial and anti-inflammatory activities of seed extracts from six Nigella species. J. Med. Food 12 (2009), 408–415.
74. Latiff, L.A., Parhizkar, S., Dollah, M.A., Hassan, S.T., Alternative supplement for enhancement of reproductive health and metabolic profile among perimenopausal women: a novel role of Nigella sativa. Iran. J. Basic Med. Sci. 17 (2014), 980–985.
75. Le, P.M., Benhaddou-Andaloussi, A., Elimadi, A., Settaf, A., Cherrah, Y., Haddad, P.S., The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. J. Ethnopharmacol. 94 (2004), 251–259.
76. Mahfouz, M., Abdel-Maguid, R., El-Dakhakhny, M., The effect of “nigellone therapy” on the histaminopexic power of the blood sera in asthmatic patients. Arznei. Forsch. Drug Res. 15 (1965), 1230–1234.
77. Mahfouz, M., El-Dakhakhny, M., The isolation of a crystalline active principle from Nigella sativa seeds. J. Pharm. Sci. UAR 1 (1960), 9–19.
78. Mahmoud, M.R., El-Abhar, H.S., Saleh, S., The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. J. Ethnopharmacol. 79 (1991), 1–11.
79. Mahmoud, S.S., Torchilin, V.P., Hormetic/cytotoxic effects of Nigella sativa seed alcoholic and aqueous extracts on MCF-7 breast cancer cells alone or in combination with doxorubicin. Cell Biochem. Biophys. 66 (2013), 451–460.
80. Mansour, M., Tornhamre, S., Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone. J. Enzym. Inhib. Med. Chem. 19 (2004), 431–436.
81. Mat, M.C., Mohamed, A.S., Hamid, S.S., Primary human monocyte differentiation regulated by Nigella sativa pressed oil. Lipids Health Dis., 10, 2011, 216.
82. Matthau, S.B., Ozcan, M.M., Fatty acids, tocopherol, and sterol contents of some Nigella species seed oil. Czech J. Food Sci. 29 (2011), 145–150.
83. Meddah, B., Ducroc, R., El Abbes Faouzi, M., Eto, B., Mahraoui, L., Benhaddou-Andaloussi, A., Martineau, L.C., Cherrah, Y., Haddad, P.S., Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. J. Ethnopharmacol. 121 (2009), 419–424.
84. Memon, A.R., Shah, S.S., Memon, A.R., Naqvi, S.H.R., Effect of combination of Nigella sativa and Trigonella foenum-graecum with glibenclamide on serum triglycerides, HDL, and creatinine levels in type 2 diabetes mellitus patients. Pak. J. Pharmacol. 29 (2012), 1–6.
85. Mohamed, A., Shoker, A., Bendjelloul, F., Mare, A., Alzrigh, M., Benghuzzi, H., Desin, T., Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. Biomed. Sci. Instrum. 39 (2003), 440–445.
86. Mohamed, A., Waris, H.M., Ramadan, H., Quereshi, M., Kalra, J., Amelioration of chronic relapsing experimental autoimmune encephalomyelitis (cr-eae) using thymoquinone - biomed 2009. Biomed. Sci. Instrum. 45 (2009), 274–279.
87. Najmi, A., Nasiruddin, M., Khan, R.A., Haque, S.F., Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. Int. J. Diabetes Dev. Ctries 28 (2008), 11–14.
88. Najmi, A., Nasiruddin, M., Khan, R.A., Haque, S.F., Therapeutic effect of Nigella sativa in patients of poor glycemic control. Asian J. Pharm. Clin. 5 (2012), 224–228.
89. Nasir, A., Siddiqui, M., Mohsin, M., Therapeutic uses of shoneez (Nigella sativa Linn.) mentioned in unani system of medicine – a review. Int. J. Pharm. Phytopharm. Res. 4 (2014), 47–49.
90. Nergiz, C., Ötleş, S., Chemical composition of Nigella sativa L. seeds. Food Chem. 48 (1993), 259–261.
91. Ng, W.K., Yazan, L.S., Ismail, M., Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein. Toxicol. Vitr. 25 (2011), 1392–1398.
92. Nickavar, B., Mojab, F., Javidnia, K., Amoli, M.A., Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z. Nat. C. 58 (2003), 629–631.
93. Nikakhlagh, S., Rahim, F., Aryani, F.H.N., Syahpoush, A., Brougerdnya, M.G., Saki, N., Herbal treatment of allergic rhinitis: the use of Nigella sativa. Am. J. Otolaryngol. 32 (2011), 402–407.
94. Paarakh, P.M., Nigella sativa Linn. A comprehensive review. Indian J. Nat. Prod. Resour. 1 (2010), 409–429.
95. Peng, L., Liu, A., Shen, Y., Xu, H.Z., Yang, S.Z., Ying, X.Z., Liao, W., Liu, H.X., Lin, Z.Q., Chen, Q.Y., Cheng, S.W., Shen, W.D., Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-kappaB pathway. Oncol. Rep. 29 (2013), 571–578.
96. Polat, R., Satil, F., Cakilcioglu, U., Medicinal plants and their use properties of sold in herbal market in Bingoel(Turkey) district. Biol. Divers. Conserv. 4 (2011), 25–35.
97. Qidwai, W., Hamza, H.B., Qureshi, R., Gilani, A., Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial. J. Altern. Complement. Med. 15 (2009), 639–644.
98. Qidwai, W., Ashfaq, T., Effect of dietary supplementation of black seed (N. Sativa L.) on lipid profile of patients suffering from diabetes. Antiinflamm. Antiallergy Agents Med. Chem. 13 (2014), 3–8.
99. Rafati, S., Niakan, M., Naseri, M., Anti-microbial effect of Nigella sativa seed extract against staphylococcal skin Infection. Med. J. Islam. Repub. Iran., 28, 2014, 42.
100. Rakhshandeh, H., Vahdati-Mashhadian, N., khajekaramadini, M., In vitro and in vivo study of the antibacterial effects of Nigella sativa methanol extract in dairy cow mastitis. Avicenna J. Phytomed. 1 (2011), 29–35.
101. Randhawa, M.A., Alghamdi, M.S., Anticancer activity of Nigella sativa (black seed) – a review. Am. J. Chin. Med. 39 (2011), 1075–1091.
102. Rchid, H., Chevassus, H., Nmila, R., Guiral, C., Petit, P., Chokairi, M., Sauvaire, Y., Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated Langerhans islets. Fundam. Clin. Pharmacol. 18 (2004), 525–529.
103. Roepke, M., Diestel, A., Bajbouj, K., Walluscheck, D., Schonfeld, P., Roessner, A., Schneider-Stock, R., Gali-Muhtasib, H., Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biol. Ther. 6 (2007), 160–169.
104. Sabzghabaee, A.M., Dianatkhah, M., Sarrafzadegan, N., Asgary, S., Ghannadi, A., Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial. Med. Arch. 66 (2012), 198–200.
105. Salem, E.M., Yar, T., Bamosa, A.O., Al-Quorain, A., Yasawy, M.I., Alsulaiman, R.M., Randhawa, M.A., Comparative study of Nigella sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. Saudi J. Gastroenterol. 16 (2010), 207–214.
106. Salem, M.L., Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int. Immunopharmacol. 5 (2005), 1749–1770.
107. Salman, M.T., Khan, R.A., Shukla, I., Antimicrobial activity of Nigella sativa Linn. Seed oil against multi-drug resistant bacteria from clinical isolates. Nat. Prod. Radiance 7 (2008), 10–14.
108. Shabana, A., El-Menyar, A., Asim, M., Al-Azzeh, H., Al Thani, H., Cardiovascular benefits of black cumin (Nigella sativa). Cardiovasc. Toxicol. 13 (2013), 9–21.
109. Shahraki, S., Khajavirad, A., Shafei, M.N., Mahmoudi, M., Tabasi, N.S., Effect of total hydroalcholic extract of Nigella sativa and its n-hexane and ethyl acetate fractions on ACHN and GP-293 cell lines. J. Tradit. Complement. Med., 2015, 1–8.
110. Shawki, M., El Wakeel, L., Shatla, R., El-Saeed, G., Ibrahim, S., Badary, O., The clinical outcome of adjuvant therapy with black seed oil on intractable paediatric seizures: a pilot study. Epileptic Disord. 15 (2013), 295–301.
111. Susanti, N., Barlianto, W., Kalim, H., Kusuma, H.M.S.C., Asthma clinical improvement and reduction in the number of CD4+CD25+foxp3+Treg and CD4+IL-10+cells after administration of immunotherapy house dust mite and adjuvant probiotics and/or Nigella sativa powder in mild asthmatic children. IOSR-JDMS 7 (2013), 50–59.
112. Swamy, S.M., Tan, B.K., Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativa L. seeds. J. Ethnopharmacol. 70 (2000), 1–7.
113. Tauseef Sultan, M., Butt, M.S., Anjum, F.M., Safety assessment of black cumin fixed and essential oil in normal Sprague Dawley rats: Serological and hematological indices. Food Chem. Toxicol. 47 (2009), 2768–2775.
114. Tembhurne, S.V., Feroz, S., More, B.H., Sakarkar, D.M., A review on therapeutic potential of Nigella sativa (kalonji) seeds. J. Med. Plants Res. 8 (2011), 167–177.
115. Wienkotter, N., Hopner, D., Schutte, U., Bauer, K., Begrow, F., El-Dakhakhny, M., Verspohl, E.J., The effect of nigellone and thymoquinone on inhibiting trachea contraction and mucociliary clearance. Planta Med. 74 (2008), 105–108.
116. Winkler, C., Schroecksnadel, K., Ledochowski, M., Schennach, H., Houcher, B., Fuchs, D., In vitro effects of Nigella sativa seeds extracts on stimulated peripheral. Blood Mononucl. Cells Pteridines 19 (2008), 101–106.
117. Woo, C.C., Kumar, A.P., Sethi, G., Tan, K.H., Thymoquinone: potential cure for inflammatory disorders and cancer. Biochem. Pharmacol. 83 (2012), 443–451.
118. Yousefi, M., Barikbin, B., Kamalinejad, M., Abolhasani, E., Ebadi, A., Younespour, S., Manouchehrian, M., Hejazi, S., Comparison of therapeutic effect of topical Nigella with Betamethasone and Eucerin in hand eczema. J. Eur. Acad. Dermatol. Venereol. 27 (2013), 1498–1504.
119. Zaoui, A., Cherrah, Y., Lacaille-Dubois, M.A., Settaf, A., Amarouch, H., Hassar, M., Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Therapie 55 (2000), 379–382.
120. Zaoui, A., Cherrah, Y., Mahassini, N., Alaoui, K., Amarouch, H., Hassar, M., Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine 9 (2002), 69–74.
121. Zohary, D., Hopf, M., Weiss, E., Domestication of Plants in the Old World: The Origin and Spread of Domesticated Plants in Southwest Asia, Europe, and the Mediterranean Basin. 2012, OUP, Oxford.